Development of an evidence
based (S3-) guideline for the therapy of Psoriasis
The guideline group is coordinated
by Dr. Alexander Nast, MD.
The head researcher is Prof. Berthold
Rzany, MD Sc.M..
Further
information for you is available >>here.
Contact:
Alexander Nast, MD
Tel.: +49 (0) 30 450 518 306
Fax: +49 (0) 30 450 518 927
Prof. Dr.
med. B. Rzany MD Sc.M
Tel.: +49 (0) 30 450 518 273
Fax: +49 (0) 30 450 518 927
Development of an evidence
based (S3-) EU-guideline for the therapy of Psoriasis
and Psoriatic arthritis
The European guideline group is coordinated
by Dr. Natalie Reytan, MD and Dr. Alexander Nast, MD.
The head researcher is Prof. Berthold
Rzany, MD Sc.M..
Further
information for you is available >>here.
Contact:
Natalie L. Reytan, MD
Tel.: +49 (0) 30 450 518 264
Fax: +49 (0) 30 450 518 927
Alexander
Nast, MD
Tel.: +49 (0) 30 450 518 306
Fax: +49 (0) 30 450 518 927
Prof. Dr.
med. B. Rzany MD Sc.M
Tel.: +49 (0) 30 450 518 273
Fax: +49 (0) 30 450 518 927
Evaluation study regarding
the German S3 guideline for the therapy of Psoriasis
The study is coordinated by Dr. Alexander Nast, MD and
Dr. Natalie Reytan, MD.
The head researcher is Professor B. Rzany, MD Sc.M..
Further
information for you is available >> here.
Contact:
Natalie L. Reytan, MD
Tel.: +49 (0) 30 450 518 264
Fax: +49 (0) 30 450 518 927
Alexander
Nast, MD
Tel.: +49 (0) 30 450 518 306
Fax: +49 (0) 30 450 518 927
Prof. Dr.
med. B. Rzany Sc.M, MD, PhD
Tel.: +49 (0) 30 450 518 273
Fax: +49 (0) 30 450 518 927
Development of an evidence based guideline
(S 3) concerning the recommendation of the HPV vaccine
use to prevent HPV associated anogenital neoplasia
The coordination of the guideline group is conducted
by Dr Delano Pathirana.
Prof. Dr. med. B. Rzany Sc.M. is the methodological
supervisor.
Further information
for you is available >> here
Contact:
Delano
Pathirana, MD
Tel.: +49 (0) 30 450 518 264
Fax: +49 (0) 30 450 518 927
Prof. Dr. med.
B. Rzany Sc.M, MD, PhD
Tel.:
+49 (0) 30 450 518 273
Fax: +49 (0) 30 450 518 927
